Carboplatin Plus Docetaxel (Taxotere) in Anaplastic Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Docetaxel
Related studies linked through entity extraction aliases.
Bexarotene, Tretinoin, and Combination Chemotherapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
An Open-Label Study of YM155 + Docetaxel in Subjects With Advanced Hormone Refractory Prostate Cancer and Other Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Panitumumab Chemoradiotherapy Chemotherapy for Squamous Cancer of the Head and Neck
- Status
- COMPLETED
- Phase
- PHASE1
Docetaxel, Cisplatin (TP) + Radiation +/- Cetuximab in Larynx Carcinoma (CA)
- Status
- COMPLETED
- Phase
- PHASE2
Avastin in Combination With Docetaxel in Ovarian/Fallopian Tube/Peritoneum Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2
A Phase I/II Study of Azacitidine, Docetaxel, and Prednisone for Metastatic Prostate Cancer Patients
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
A Study to Assess Safety, Tolerability and PK of AZD2171 and Chemotherapy on Patients With Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Induction Chemotherapy Prior to Radio-immunotherapy in Head and Neck Cancer Stage III/IV - a Methodical Trial
- Status
- COMPLETED
- Phase
- NA
Hormonal Ablation, Imatinib Mesylate and Docetaxel for Patients With Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE2
NOV-002, Doxorubicin, Cyclophosphamide, and Docetaxel in Women With Newly Diagnosed Stage II or IIIC Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Phase III of RRM1 & ERCC1 Directed Customized Chemotherapy for the Treatment of Patients With NSCLC
- Status
- COMPLETED
- Phase
- PHASE3
Combination Chemotherapy and Radiation Therapy With or Without Lapatinib in Treating Patients With Locally Advanced Cancer of the Larynx or Hypopharynx
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
E3-Hormone Refractory Prostrate Cancer Taxotere Combination
- Status
- COMPLETED
- Phase
- PHASE2
E3 Breast Cancer Taxotere Combination
- Status
- COMPLETED
- Phase
- PHASE2
Phase II Trial of Docetaxel and Celecoxib in Patients With Androgen Independent Prostate Cancer
- Status
- TERMINATED
- Phase
- PHASE2
TAC Versus TC for Adjuvant Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE3
A Phase II Combination of Trastuzumab and Ixabepilone Versus Trastuzumab and Docetaxel in Patients With Advanced and/or Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Intermittent Chemotherapy With or Without Granulocyte-macrophage Colony-stimulating Factor (GM-CSF) for Metastatic Hormone Refractory Prostate Cancer (HRPC)
- Status
- COMPLETED
- Phase
- PHASE2
Safety Study of an Antisense Product in Prostate, Ovarian, NSCL, Breast or Bladder Cancer
- Status
- COMPLETED
- Phase
- PHASE1